Farallon Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Farallon Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-340,000	Closed	-$40M	–	102
2015 Q3	$40M	Sell	340,000 -420,000	-55%	-$54.9M	0.53%	43
2015 Q2	$58.8M	Sell	760,000 -400,000	-34%	-$26.2M	0.79%	36
2015 Q1	$67.1M	Sell	1,160,000 -225,000	-16%	-$9.55M	0.98%	36
2014 Q4	$44.7M	Buy	1,385,000 +450,000	+48%	+$13.5M	0.61%	43
2014 Q3	$22.9M	Buy	935,000 +501,186	+116%	+$10.2M	0.37%	55
2014 Q2	$7.69M	Sell	433,814 -66,186	-13%	-$1.07M	0.11%	73
2014 Q1	$10M	Sell	500,000 -62,352	-11%	-$1.21M	0.2%	62
2013 Q4	$9.44M	Buy	562,352 +112,352	+25%	+$1.55M	0.2%	59
2013 Q3	$4.78M	Sell	450,000 -187,500	-29%	-$1.64M	0.1%	66
2013 Q2	$3.56M	Buy	+637,500	New	+$3.86M	0.07%	70

Other funds holding ANAC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

RCP

Rho Capital Partners New York $20.4M AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Farallon Capital Management's ANAC Position: Q4 2015 in Review

Farallon Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2015, closing a stake of 340,000 shares — an estimated $40M sold.

Farallon Capital Management first reported a position in ANAC in Q2 2013 and held it in 10 quarters. The position peaked at $67.1M in Q1 2015. 214 funds tracked by Wall St. Rank hold ANAC as of Q4 2015.

Farallon Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2015 after selling out during the quarter.
Farallon Capital Management sold 340,000 ANACOR PHARMACEUTICALS INC COM shares in Q4 2015, an estimated $40M.
Farallon Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 10 quarters.
Farallon Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $67.1M in Q1 2015.
214 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2015.

Based on Farallon Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.